Suture polyglactin 910 no.6/0 RC 45 cm, 1/4 circle 8 mm
Suture Polyglactin 910 Size 6/0 is an extra-fine absorbable suture for microsurgery and ophthalmology. It features a tiny 8mm Reverse Cutting needle with a 1/4 circle curvature (often used for eyes or eyelids). The 6/0 gauge is hair-thin, leaving virtually no scar. The cutting needle is designed to penetrate the cornea, sclera, or delicate facial skin. Thread length is shorter (45cm) for manageability under a microscope.
Polyglactin 910 Size 6/0 with an 8mm Microsurgical Needle is a high-precision product.
Features:
– Gauge: 6/0 (Metric 0.7). Extremely fine.
– Needle: 8mm length, 1/4 Circle (lighter curve than standard), Reverse Cutting / Spatula (often spatulated for eyes). Designed to pass through thin layers without tearing.
– Length: 45cm. Short length prevents tangling during microsurgery.
Indications:
– Ophthalmic Surgery: Eyelid repair, conjunctival closure.
– Plastic Surgery: Face and ear reconstruction.
– Microsurgery: Nerve or small vessel repair (though nylon is often preferred, polyglactin is used where absorption is needed).
Handling: Requires delicate instruments (micro-needle drivers) to avoid bending the tiny needle.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.

Reviews
There are no reviews yet.